Gilead Sciences GILD
NASDAQ GILD
$150.11 -0.78 (-0.52%)
At close: Sep 18, 2026 · 4:00 PM EDT

Gilead Sciences (GILD) Amortizatization of Intangibles (2009 - 2026)

Gilead Sciences' (GILD) quarterly Amortizatization of Intangibles came in at $600.0 million in Q2 2026, little changed on a YoY basis from $598.0 million in Q2 2025, and up 0.67% quarter-over-quarter from $596.0 million in Q1 2026.

Analysis

Gilead Sciences (GILD) Amortizatization of Intangibles (2009 - 2026) Analysis & Trends

Gilead Sciences (GILD) has reported Amortizatization of Intangibles for 18 consecutive years, with $600.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Amortizatization of Intangibles changed 0.33% year-over-year to $600.0 million; the trailing twelve-month figure through Jun 2026 stood at $2.4 billion (changed 0.08% YoY), and the FY2025 full-year result was $2.4 billion, changed 0.17% from the prior year.
  • Amortizatization of Intangibles rose to $600.0 million in Q2 2026 per GILD's latest filing, from $596.0 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $600.0 million in Q2 2026 and bottomed at $445.0 million in Q1 2022.
  • Historically, Amortizatization of Intangibles has averaged $560.6 million across 5 years, with a median of $596.0 million in 2024.
  • The sharpest annual moves came in 2023 and 2026: Amortizatization of Intangibles jumped 34.38% in 2023, then declined 0.5% in 2026.
  • Over 5 years, Amortizatization of Intangibles stood at $445.0 million in 2022, then soared by 34.16% to $597.0 million in 2023, then gained by 0.17% to $598.0 million in 2024, then fell by 0.17% to $597.0 million in 2025, then climbed by 0.5% to $600.0 million in 2026.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $600.0 million, $596.0 million, and $597.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn -
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn 600.00 Mn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn -
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn -
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn -
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn -
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn 1.39 Mn
10 Insmed 26.19 Bn 25.03 Bn 358.27 Mn 678,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 600.00 Mn
Mar 31, 2026 596.00 Mn
Dec 31, 2025 597.00 Mn
Sep 30, 2025 596.00 Mn
Jun 30, 2025 598.00 Mn
Mar 31, 2025 599.00 Mn
Dec 31, 2024 598.00 Mn
Sep 30, 2024 596.00 Mn
Jun 30, 2024 596.00 Mn
Mar 31, 2024 596.00 Mn
Dec 31, 2023 597.00 Mn
Sep 30, 2023 598.00 Mn
Jun 30, 2023 598.00 Mn
Mar 31, 2023 546.00 Mn
Dec 31, 2022 445.00 Mn
Sep 30, 2022 445.00 Mn
Jun 30, 2022 445.00 Mn
Mar 31, 2022 445.00 Mn
Dec 31, 2021 445.00 Mn
Sep 30, 2021 441.00 Mn